Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Barrett

Showing results (1-10 of 573) with videos related to

Pageof 58
Sort By:
The Oklahoma Nurse|November 1, 1980
A disaster experienceF Barrett
Expert Opinion on Therapeutic Targets|December 9, 2004
MRSA: status and prospects for therapy? An evaluation of key papers on the topic of MRSA and antibiotic resistanceJohn F Barrett
Expert Opinion on Drug Safety|December 24, 2005
Potential risk of probiotic usageJohn F Barrett
Current Opinion in Investigational Drugs (London, England : 2000)|January 31, 2002
MC-207110 Daiichi Seiyaku/Microcide PharmaceuticalsJ F Barrett
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
Moxifloxacin BayerJ F Barrett
Current Opinion in Investigational Drugs (London, England : 2000)|August 27, 2005
Recent developments in glycopeptide antibacterialsJohn F Barrett
Frontiers in Human Neuroscience|September 18, 2014
A dynamic systems view of habitsNathaniel F Barrett
Expert Opinion on Pharmacotherapy|May 5, 2001
Antimicrobial resistance--should we be concerned?J F Barrett
Expert Opinion on Investigational Drugs|February 24, 2001
SMI's 2nd Annual Superbugs and Superdrugs Conference: innovations in anti-infectivesJ F Barrett
Journal of the American Academy of Religion. American Academy of Religion|October 1, 2010
Toward an alternative evolutionary theory of religion: looking past computational evolutionary psychology to a wider field of possibilitiesNathaniel F Barrett
Pageof 58

Showing results (1-10 of 573) with videos related to

Sort By:
Pageof 58
The Oklahoma Nurse|November 1, 1980
A disaster experienceF Barrett
Expert Opinion on Therapeutic Targets|December 9, 2004
MRSA: status and prospects for therapy? An evaluation of key papers on the topic of MRSA and antibiotic resistanceJohn F Barrett
Expert Opinion on Drug Safety|December 24, 2005
Potential risk of probiotic usageJohn F Barrett
Current Opinion in Investigational Drugs (London, England : 2000)|January 31, 2002
MC-207110 Daiichi Seiyaku/Microcide PharmaceuticalsJ F Barrett
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
Moxifloxacin BayerJ F Barrett
Current Opinion in Investigational Drugs (London, England : 2000)|August 27, 2005
Recent developments in glycopeptide antibacterialsJohn F Barrett
Frontiers in Human Neuroscience|September 18, 2014
A dynamic systems view of habitsNathaniel F Barrett
Expert Opinion on Pharmacotherapy|May 5, 2001
Antimicrobial resistance--should we be concerned?J F Barrett
Expert Opinion on Investigational Drugs|February 24, 2001
SMI's 2nd Annual Superbugs and Superdrugs Conference: innovations in anti-infectivesJ F Barrett
Journal of the American Academy of Religion. American Academy of Religion|October 1, 2010
Toward an alternative evolutionary theory of religion: looking past computational evolutionary psychology to a wider field of possibilitiesNathaniel F Barrett
Pageof 58